HRT Financial
LBRX icon

HRT Financial’s LB Pharmaceuticals LBRX Stock Holding History

HRT Financial’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562K Buy
+17,325
New +$509K ﹤0.01% 2561
2025
Q4 		– Sell
-58,815
Closed -$928K – 4348
2025
Q3 		$928K Buy
+58,815
New +$933K ﹤0.01% 1560

Other funds holding LBRX

Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Trails Edge Capital Partners
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Commodore Capital
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

HRT Financial's LBRX Position: Q2 2026 in Review

HRT Financial opened a new position in LB Pharmaceuticals (LBRX) in Q2 2026: 17,325 shares worth $562K. The stake represents ﹤0.01% of the portfolio and ranks #2561 among its holdings. This is a return to the name: HRT Financial previously reported a position in LBRX as recently as Q3 2025.

HRT Financial first reported a position in LBRX in Q3 2025 and has held it in 2 quarters since. The position peaked at $928K in Q3 2025. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • HRT Financial held 17,325 shares of LB Pharmaceuticals worth $562K as of Q2 2026.
  • LB Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • LB Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2561 holding.
  • HRT Financial first reported a position in LB Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • HRT Financial's LB Pharmaceuticals position peaked at $928K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.